NO920394L - Terapeutisk aktive inositol-analoger og fremgangsmaate forderes fremstilling - Google Patents

Terapeutisk aktive inositol-analoger og fremgangsmaate forderes fremstilling

Info

Publication number: NO920394L
Authority: NO; Norway
Prior art keywords: therapeutically active; procedure continues; inositol analogs; continues preparation; active inositol
Prior art date: 1991-02-01

Application number

NO92920394A

Other languages

English (en)

Norwegian (no)

Other versions

NO920394D0 (no

Inventor

Mario Brufani

Maria Candida Cesta

Enrico Ferrari

Luigi Filocamo

Sperandina Lappa

Stefano Maiorana

Pier Giuseppe Pagella

Original Assignee

Mediolanum Farmaceutici Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-02-01

Filing date

1992-01-30

Publication date

1992-08-03

1992-01-30 Application filed by Mediolanum Farmaceutici Spa filed Critical Mediolanum Farmaceutici Spa

1992-01-30 Publication of NO920394D0 publication Critical patent/NO920394D0/no

1992-08-03 Publication of NO920394L publication Critical patent/NO920394L/no

Links

150000004001 inositols Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/16—Esters of thiophosphoric acids or thiophosphorous acids
- C07F9/165—Esters of thiophosphoric acids
- C07F9/177—Esters of thiophosphoric acids with cycloaliphatic alcohols
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Hematology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Engineering & Computer Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO92920394A 1991-02-01 1992-01-30 Terapeutisk aktive inositol-analoger og fremgangsmaate forderes fremstilling NO920394L (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
ITMI910251A IT1244546B (it)	1991-02-01	1991-02-01	Analoghi del fosfatidilinositolo inibitori della fosfolipasi c fosfatidilinositolo-specifica

Publications (2)

Publication Number	Publication Date
NO920394D0 NO920394D0 (no)	1992-01-30
NO920394L true NO920394L (no)	1992-08-03

Family

ID=11358370

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO92920394A NO920394L (no)	1991-02-01	1992-01-30	Terapeutisk aktive inositol-analoger og fremgangsmaate forderes fremstilling

Country Status (10)

Country	Link
US (1)	US5352810A (ja)
EP (1)	EP0497234A3 (ja)
JP (1)	JPH05213974A (ja)
KR (1)	KR920016460A (ja)
AU (1)	AU651658B2 (ja)
CA (1)	CA2060083A1 (ja)
IE (1)	IE920312A1 (ja)
IT (1)	IT1244546B (ja)
NO (1)	NO920394L (ja)
ZA (1)	ZA92584B (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2694936B1 (fr) *	1992-08-18	1994-11-25	Bayer Pharma	Dérivés substitués du désoxy-myoinositol, procédé pour leur préparation et leur utilisation dans des médicaments.
US20020107193A1 (en) *	2000-11-09	2002-08-08	Glazner Gordon W.	Therapeutic uses for IP3 receptor-mediated calcium channel modulators
GB0127206D0 (en) *	2001-11-13	2002-01-02	Univ Liverpool	Treatment of inflammatory conditions
CA2491555C (en) *	2002-07-10	2012-09-11	Massachusetts Institute Of Technology	Solid-phase and solution-phase synthesis of glycosylphosphatidylinositol glycans
EP1566447A1 (en) *	2004-02-20	2005-08-24	Aventis Pharma Deutschland GmbH	Glimepiride- and insulin-induced glycosylphosphatidylinositol-specific phospholipase C regulation
US9017724B2 (en)	2004-02-24	2015-04-28	The General Hospital Corporation	Catalytic radiofluorination
US8257680B1 (en)	2004-02-24	2012-09-04	The General Hospital Corporation	Catalytic radiofluorination
EP3231804B1 (en) *	2008-03-21	2021-03-03	The General Hospital Corporation	Compounds and compositions for the detection and treatment of alzheimer's disease and related disorders
CN114460203B (zh) *	2022-02-15	2023-12-22	浙江海正药业股份有限公司	一种同时检测药物中对甲苯亚磺酸甲酯、对甲苯亚磺酸乙酯、对甲苯亚磺酸异丙酯的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2287901A1 (fr) *	1974-10-14	1976-05-14	Pasteur Institut	Medicament immunostimulant contenant un derive d'ose ou de polyose phosphoryle
DE2659048A1 (de) *	1976-12-27	1978-07-06	Nattermann A & Cie	Neue inositphosphatid-derivate und verfahren zur herstellung dieser verbindungen
US4515722A (en) *	1982-03-30	1985-05-07	Merck & Co., Inc.	Phosphatidyl inositol analogs useful as anti-inflammatory/analgesic agents
DE3239817A1 (de) *	1982-07-06	1984-01-12	Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen	Neue glycerinderivate zur synthese von phospholipiden
US4585762A (en) *	1982-07-30	1986-04-29	Fujisawa Pharmaceutical Co., Ltd.	Phospholipid derivatives, processes for use thereof and pharmaceutical composition of the same

1991
- 1991-02-01 IT ITMI910251A patent/IT1244546B/it active IP Right Grant
1992
- 1992-01-23 US US07/824,318 patent/US5352810A/en not_active Expired - Fee Related
- 1992-01-27 CA CA002060083A patent/CA2060083A1/en not_active Abandoned
- 1992-01-27 EP EP19920101226 patent/EP0497234A3/en not_active Withdrawn
- 1992-01-28 ZA ZA92584A patent/ZA92584B/xx unknown
- 1992-01-30 IE IE031292A patent/IE920312A1/en unknown
- 1992-01-30 AU AU10648/92A patent/AU651658B2/en not_active Expired - Fee Related
- 1992-01-30 NO NO92920394A patent/NO920394L/no unknown
- 1992-01-31 KR KR1019920001516A patent/KR920016460A/ko not_active Withdrawn
- 1992-01-31 JP JP4042426A patent/JPH05213974A/ja active Pending

Also Published As

Publication number	Publication date
AU1064892A (en)	1992-08-06
KR920016460A (ko)	1992-09-24
ITMI910251A0 (it)	1991-02-01
ZA92584B (en)	1992-10-28
EP0497234A3 (en)	1993-06-02
ITMI910251A1 (it)	1992-08-01
JPH05213974A (ja)	1993-08-24
AU651658B2 (en)	1994-07-28
EP0497234A2 (en)	1992-08-05
CA2060083A1 (en)	1992-08-02
IE920312A1 (en)	1992-08-12
US5352810A (en)	1994-10-04
IT1244546B (it)	1994-07-15
NO920394D0 (no)	1992-01-30

Publication	Publication Date	Title
FI922785A7 (fi)	1992-12-29	Terapeuttisia valmisteita
KR910700249A (ko)	1991-03-14	신규 치료학적 활성 화합물 및 그의 제조 방법
DK481989D0 (da)	1989-09-29	Farmaceutiske formuleringer
FI923379L (fi)	1993-01-26	Terapeutiska amider
FI920737A7 (fi)	1992-02-20	Terapeuttisia peptidejä
DE68927186D1 (de)	1996-10-17	Video-endoskop
NO178688C (no)	1996-05-15	Administrerings-innretning
NO934009L (no)	1993-11-05	Farmasoeytiske formuleringer
EP0460064A4 (en)	1992-04-01	Therapeutic aerosol formulations
DK551187D0 (da)	1987-10-21	Terapeutisk praeparat og dettes fremstilling
FI934189A7 (fi)	1993-09-24	Transdermalt terapeutiskt plaoster
FI934913A7 (fi)	1993-11-05	Liposomaalisia prostaglandiiniformulaatioita
FI923663A7 (fi)	1993-02-16	Terapeutiska foereningar
DK287188D0 (da)	1988-05-25	Cephalosporinforbindelser og farmaceutisk praeparat deraf
NO920394D0 (no)	1992-01-30	Terapeutisk aktive inositol-analoger og fremgangsmaate forderes fremstilling
FI923759L (fi)	1992-08-20	Terapeutiska bensazapinfoereningar
FI930674L (fi)	1993-02-16	Terapeutiska aemnen
DK394084D0 (da)	1984-08-16	Fysiologisk aktive praeparater
NO914071D0 (no)	1991-10-17	Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser
DK440188D0 (da)	1988-08-05	Antiemetisk virksomme praeparater
TR23355A (tr)	1989-12-19	Naftasen'lerin hazirlanmasi icin usul
NO304428B1 (no)	1998-12-14	AnalogifremgangsmÕte for fremstilling av terapeutisk aktive vinylazoler
DK64688D0 (da)	1988-02-09	Nukleotidanaloger og fremstilling og anvendelse deraf
FI931071L (fi)	1993-03-10	Terapeutiska aemnen
DK316386D0 (da)	1986-07-03	Terapeutisk aktive benzamider og fremgangsmaade til fremstilling af saadanne